UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
MARS ACQUISITION CORP.
(Name of Issuer)
Ordinary Shares, par value $0.000125 per share
(Title of Class of Securities)
G5870E 132
(CUSIP Number)
Iris Zhao
Americas Tower, 1177 Avenue of The Americas, Suite 5100
New York, NY (10036)
Telephone: (888) 622-1218
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
February 13, 2023
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 3d-1(f) or 13d-1(g), check the following box. ¨
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13D
CUSIP No. G5870E 132
| 1 |
Name of reporting persons I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Karl A. Brenza | |
| 2 |
Check the appropriate box if a member of a group
(a) ¨ (b) ¨ | |
| 3 |
SEC use only
| |
| 4 |
Source of funds
OO | |
| 5 |
Check box if disclosure of legal proceedings is required pursuant to Item 2(d) or 2(e)
¨ | |
| 6 |
Citizenship or place of organization
United States of America |
|
Number of shares beneficially owned by each reporting person with |
7 |
Sole voting power
345,000 | ||
| 8 |
Shared voting power
| |||
| 9 |
Sole dispositive voting power
345,000 | |||
| 10 |
Shared dispositive power
|
| 11 |
Aggregate amount beneficially owned by each reporting person
345,000 | |
| 12 |
Check box if the aggregate amount in row (11) excludes certain shares
¨ | |
| 13 |
Percent of class represented by amount in row (11)
7.71 % | |
| 14 |
Type of reporting person
IN |
SCHEDULE 13D
CUSIP No. G5870E 132
This statement relates (the “Schedule 13D”) to the ordinary shares, par value $0.00125 (the “Ordinary Share”), issued by Mars Acquisition Corp. (the “Issuer”). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D. Except as otherwise provided herein, each Item of the Schedule 13D remains unchanged.
Item 1. Security and Issuer.
Securities acquired: Ordinary Shares, $0.000125 par value.
| Issuer: | Mars Acquisition Corp. |
| Americas Tower, 1177 Avenue of The Americas, Suite 5100 | |
| New York, NY, 10036 |
Item 2. Identity and Background.
(a) Name: This statement is filed by Karl Brenza (the “Reporting Person”).
(b) Principal Business Address: The principal business address of the Reporting Person is Americas Tower, 1177 Avenue of The Americas, Suite 5100, New York, NY (10036).
(c) Present Principal Occupation: The Reporting Person is the Chief Executive Officer, Chief Financial Officer and director of the Issuer.
(d) Convictions: During the past five years, the Reporting Person has not been convicted in a criminal proceeding.
(e) Civil Proceedings: During the past five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was the subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal and state securities laws of findings any violation with respect to such laws.
(f) Citizenship: The Reporting Person is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration.
The information set forth in Items 4 of this Schedule 13D are hereby incorporated by reference into this Item 3.
Item 4. Purpose of Transaction.
On May 31, 2021, the Issuer issued 431,250 ordinary shares, at par value $0.0001 to the Reporting Person, for approximately $0.012 per share.
On December 1, 2022, Issuer effectuated a share consolidation at a ratio of 1 for 1.25. Every 1.25 shares were consolidated into 1 share, pursuant to a written resolutions by all of the shareholders of the Issuer dated December 1, 2022. The share consolidation reduced the number of authorized shares from 1,000,000,000, par value $0.0001 to 800,000,000, par value $0.000125. The Reporting Person’s shares were reduced from 431,250 to 345,000.
Depending on prevailing market, economic and other conditions, the Reporting Person may from time to time acquire additional Ordinary Shares or engage in discussions with the Issuer concerning future acquisitions of shares of its capital stock. Such acquisitions may be made by means of open-market purchases, privately negotiated transactions, direct acquisitions from the Issuer or otherwise.
Except as set forth in this Item 4, Reporting Person does not have any plans or proposals that relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the present board or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer’s business or corporate structure, including but not limited to, if the issuer is a registered closed-end investment company; (g) changes in the Issuer’s charter, by-laws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or (j) any action similar to any of those enumerated above.
The Reporting Person may, at any time and from time to time, formulate other purposes, plans or proposals regarding the Issuer, or any other actions that could involve one or more of the types of transactions or have one or more of the results described in clauses (a) through (j) of Item 4 of Schedule 13D.
Item 5. Interest in Securities of the Issuer.
(a) The responses to Items 11 and 13 of the cover page to this Schedule 13D are incorporated herein.
(b) The responses to Items 7 through 10 of the cover page to this Schedule 13D are incorporated herein.
(c) The Reporting Person has not entered into any transactions in the Ordinary Shares during the sixty days immediately prior to the filing of this Schedule 13D.
(d) As of the date of filing of this Schedule 13D, no person, other than the Reporting Person, is known to have had the power to direct the receipt of dividends from, or proceeds from the sale of, any of the Ordinary Shares owned by the Reporting Person.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
The information set forth in Items 4 of this Schedule 13D is hereby incorporated by reference into this Item 6.
Item 7. Materials to be Filed as Exhibits.
None.
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct.
Date: March 8, 2024
| By: | /s/ Karl Brenza | |
| Name: | Karl Brenza |